Loading…
Lobbying Spend
—
Filings
72
Firms Hired
3
Active Period
2001–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6130
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Client expense: — · Firm income: $50,000
Matched citations: HR6509
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Client expense: — · Firm income: $50,000
Matched citations: S. 3267
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794). FDA actions on drug compounding and illicit drugs. Issues related to TrumpRX. Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267).
Client expense: — · Firm income: $50,000
Matched citations: S3794
SAFE Drugs Act of 2025
2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794).
Client expense: — · Firm income: $50,000
Matched citations: HR6509
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies. SAFE Drugs Act (HR6509/S3794).
Client expense: — · Firm income: $50,000
Matched citations: S3794
Treat and Reduce Obesity Act of 2023
2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to drug pricing; Issues related to reimbursement of insulin products; H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023, Issues related to the One Big Beautiful Bill Act (PL 119-21), most favored nation pricing polices.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4818
Treat and Reduce Obesity Act of 2023
2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to drug pricing; Issues related to reimbursement of insulin products; H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023, Issues related to the One Big Beautiful Bill Act (PL 119-21), most favored nation pricing polices.
Client expense: — · Firm income: $50,000
Matched citations: S. 2407
Treat and Reduce Obesity Act of 2023
2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to drug pricing; Issues related to reimbursement of insulin products; H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023, Issues related to the One Big Beautiful Bill Act (PL 119-21), most favored nation pricing polices.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4818
Treat and Reduce Obesity Act of 2023
2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to drug pricing; Issues related to reimbursement of insulin products; H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023, Issues related to the One Big Beautiful Bill Act (PL 119-21), most favored nation pricing polices.
Client expense: — · Firm income: $50,000
Matched citations: S. 2407
Treat and Reduce Obesity Act of 2023
2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to drug pricing; Issues related to reimbursement of insulin products; H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023, Issues related to the One Big Beautiful Bill Act (PL 119-21), most favored nation pricing polices.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4818
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
International and domestic tax issues. H.R. 1, One Big Beautiful Bill Act implementation.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
Treat and Reduce Obesity Act of 2023
2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Issues related to drug pricing; Issues related to reimbursement of insulin products; H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023, Issues related to the One Big Beautiful Bill Act (PL 119-21), most favored nation pricing polices.
Client expense: — · Firm income: $50,000
Matched citations: S. 2407
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023. HR. 1, One Big Beautiful Bill Act, MFN drug pricing proposals.
Client expense: — · Firm income: $50,000
Matched citations: HR. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development and approval. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention, 340B Program. Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. H.R. 1; issues related to biopharmaceutical drug pricing, particularly related to MFN.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
Treat and Reduce Obesity Act of 2023
2024 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47. American Relief Act (P.L. 118-158).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4818
Treat and Reduce Obesity Act of 2023
2024 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47. American Relief Act (P.L. 118-158).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4818
Treat and Reduce Obesity Act of 2023
2024 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47. American Relief Act (P.L. 118-158).
Client expense: — · Firm income: $50,000
Matched citations: S. 2407
Treat and Reduce Obesity Act of 2023
2024 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47. American Relief Act (P.L. 118-158).
Client expense: — · Firm income: $50,000
Matched citations: S. 2407
Treat and Reduce Obesity Act of 2023
2024 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4818
Treat and Reduce Obesity Act of 2023
2024 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4818
Treat and Reduce Obesity Act of 2023
2024 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Client expense: — · Firm income: $50,000
Matched citations: S. 2407
Treat and Reduce Obesity Act of 2023
2024 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Client expense: — · Firm income: $50,000
Matched citations: S. 2407
Treat and Reduce Obesity Act of 2023
2024 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4818
Treat and Reduce Obesity Act of 2023
2024 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Policies impacting Medicare Part D and Part B reimbursement policies. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023, H.R. 4818, S. 2407. Public Law 118-47.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4818
Source: Senate LDA